# Xcoo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xcoo

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: www.xcoo.co.jp
- Total disclosed funding: $5.1M
- Latest round: Series A (Jul 11, 2022)
- Investors on record: 1

## About

Founded in 2011 and based in Tokyo, Japan, Xcoo, Inc., engages in the implementation of genomic medicine and intelligence using information technology. The company develops and operates Chrovis, a software specializing in genomic medical analysis and bioinformatics. In July 2022, Xcoo, Inc. raised JPY 700 million in venture funding led by new investor SPARX Group with participation from other undisclosed investors. As of 2022, the company is led by its President and Chief Executive Officer, Kunihiro Nishimura, and has 44 employees.

The company offers various bioinformatics solutions that include genomic and biological information analysis, high-speed data processing by parallel and distributed computing, and systems for data analysis and visualization. The company also provides support for medical research, personalized medicine, genomics drug discovery, and gene therapy.

The company plans to use the July 2022 funding for the expansion and development of the service provided by the company. The funds will also be invested in strengthening human resources and recruitment.

## Funding rounds

- Series A, Jul 11, 2022, $5.1M — SPARX Group

## Investors

- SPARX Group (https://capitalatlas.ai/funds/sparx-group) — Series A